CD38 and graft versus host disease: In conclusion, CD38 positive T cells regulate NAD+ metabolism in inflamed tissues and blockade of the enzymatic function of CD38 by TNB-738 could represent a novel class of therapeutics for the treatment of inflammatory conditions, including GvHD.